Combination of Oncolytic Virotherapy with Different Antitumor Approaches against Glioblastoma

被引：1
|
作者：
Ageenko, Alisa [1 ]
Vasileva, Natalia [1 ,2 ]
Richter, Vladimir [1 ]
Kuligina, Elena [1 ,2 ]
机构：
[1] Russian Acad Sci, Inst Chem Biol & Fundamental Med, Siberian Branch, Akad Lavrentiev Ave 8, Novosibirsk 630090, Russia
[2] LLC Oncostar, R&D Dept, Ingenernaya St 23, Novosibirsk 630090, Russia
来源：
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES | 2024年 / 25卷 / 04期
基金：
俄罗斯科学基金会;
关键词：
glioblastoma; oncolytic viruses; chemotherapy; radiotherapy; immunotherapy; combination therapy; HERPES-SIMPLEX-VIRUS; MEASLES-VIRUS; MALIGNANT GLIOMA; VACCINIA VIRUS; RADIATION-THERAPY; MYXOMA VIRUS; PRECLINICAL EVALUATION; CANCER-CELLS; PHASE-I; GM-CSF;
D O I：
10.3390/ijms25042042
中图分类号：
Q5 [生物化学]; Q7 [分子生物学];
学科分类号：
071010 ; 081704 ;
摘要：
Glioblastoma is one of the most malignant and aggressive tumors of the central nervous system. Despite the standard therapy consisting of maximal surgical resection and chemo- and radiotherapy, the median survival of patients with this diagnosis is about 15 months. Oncolytic virus therapy is one of the promising areas for the treatment of malignant neoplasms. In this review, we have focused on emphasizing recent achievements in virotherapy, both as a monotherapy and in combination with other therapeutic schemes to improve survival rate and quality of life among patients with glioblastoma.
引用
收藏
页数：26
相关论文
共 50 条
  • [31] The tumor immunologic microenvironment influences antitumor efficacy of oncolytic herpes simplex virotherapy
    Leddon, Jennifer L.
    Chen, Chun-Yu
    Currier, Mark
    Wang, Pin-Yi
    Jung, Francesca
    Cripe, Kevin
    Haworth, Kellie
    Eubank, Timothy
    Hildeman, David
    Cripe, Timothy
    CANCER RESEARCH, 2014, 74 (20)
  • [32] Eradication of glioblastoma by immuno-virotherapy with a retargeted oncolytic HSV in a preclinical model
    Francesco Alessandrini
    Laura Menotti
    Elisa Avitabile
    Irene Appolloni
    Davide Ceresa
    Daniela Marubbi
    Gabriella Campadelli-Fiume
    Paolo Malatesta
    Oncogene, 2019, 38 : 4467 - 4479
  • [33] Assessment for antitumor activity of telomerase-specific oncolytic virotherapy in the hypoxic microenvironment
    Hashimoto, Yuuri
    Teraishi, Fuminori
    Watanabe, Yuichi
    Sakai, Ryo
    Kuroda, Shinji
    Kagawa, Shunsuke
    Urata, Yasuo
    Tanaka, Noriaki
    Fujiwara, Toshiyoshi
    JOURNAL OF GENE MEDICINE, 2008, 10 (04): : 471 - 471
  • [34] Exploring Molecular Landscapes and Immunological Dynamics in Glioblastoma: Insights from Oncolytic Virotherapy
    Barcelos, Pedro
    Fonseca, Dennyson
    Souza, Kamilla
    Vale, Fernando
    Adri, Anny
    Nobile, Adriel
    Lucas, Yohan Lucas
    Marques, Lena
    Moll, Guido
    Rocha, Vanderson
    Nakaya, Helder
    Miranda, Gustavo
    Filgueiras, Igor
    Marques, Otavio
    CLINICAL IMMUNOLOGY, 2024, 262
  • [35] MODULATION OF THE IL-27 RECEPTOR SIGNALING PATHWAY IN GLIOBLASTOMA AND ONCOLYTIC VIROTHERAPY
    Panagioti, Eleni
    Nowicki, Michal
    Goins, William
    Macias, Jorge Jimenez
    Escobar, Julia
    Zdioruk, Mykola
    Saini, Shikha
    Ligon, Keith
    Anderson, Ana Carrizosa
    Kuchroo, Vijay Kumar
    Lawler, Sean
    Chiocca, E. Antonio
    NEURO-ONCOLOGY, 2021, 23 : 177 - 177
  • [36] UTILIZING ONCOLYTIC VIROTHERAPY AS AN APPROACH TO ENHANCE NEOANTIGEN SPECIFIC IMMUNE RESPONSES IN GLIOBLASTOMA
    Piranlioglu, Raziye
    Ahn, Ryujin
    Islam, Anan
    Nowicki, Michal
    Ling, Alexander
    Soni, Himanshu
    Ahuja, Ved V.
    Goins, William F.
    Irvine, Darrell J.
    White, Forest M.
    Nakashima, Hiroshi
    Chiocca, E. Antonio
    NEURO-ONCOLOGY, 2023, 25
  • [37] Eradication of glioblastoma by immuno-virotherapy with a retargeted oncolytic HSV in a preclinical model
    Alessandrini, Francesco
    Menotti, Laura
    Avitabile, Elisa
    Appolloni, Irene
    Ceresa, Davide
    Marubbi, Daniela
    Campadelli-Fiume, Gabriella
    Malatesta, Paolo
    ONCOGENE, 2019, 38 (23) : 4467 - 4479
  • [38] Oncolytic virotherapy in glioblastoma patients induces a tumor macrophage phenotypic shift leading to an altered glioblastoma microenvironment
    van den Bossche, Wouter B. L.
    Kleijn, Anne
    Teunissen, Charlotte E.
    Voerman, Jane S. A.
    Teodosio, Cristina
    Noske, David P.
    van Dongen, Jacques J. M.
    Dirven, Clemens M. F.
    Lamfers, Martine L. M.
    NEURO-ONCOLOGY, 2018, 20 (11) : 1494 - 1504
  • [39] Strategies for Advanced Oncolytic Virotherapy: Current Technology Innovations and Clinical Approaches
    Ji, Qing
    Wu, Yuchen
    Albers, Andreas
    Fang, Meiyu
    Qian, Xu
    PHARMACEUTICS, 2022, 14 (09)
  • [40] Oncolytic Virotherapy versus Cancer Stem Cells: A Review of Approaches and Mechanisms
    Chaurasiya, Shyambabu
    Chen, Nanhai G.
    Warner, Susanne G.
    CANCERS, 2018, 10 (04)
12345